Bioness receives FDA approval for hand rehabilitation system

The wireless device uses low-level electrical stimulation to activate the various muscle groups in the hand and forearm.

Bioness Ltd. has obtained US Food and Drug Administration (FDA) approval to market its H200 Wireless Hand Rehabilitation System, and upgrade of its H200 system for treating hand paralysis.

The device uses low-level electrical stimulation to activate the various muscle groups in the hand and forearm enabling the opening and closing of the hand, after damage caused by stroke, brain injury, spinal cord injury or cerebral palsy. The original H200 used wires and a control box, which have been replaced by a rechargeable battery to provide full mobility.

Published by Globes [online], Israel business news - www.globes-online.com - on September 21, 2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018